Literature DB >> 17890441

Ultrasensitive flow-based immunoassays using single-molecule counting.

John Todd1, Bob Freese, Ann Lu, Douglas Held, Jennifer Morey, Richard Livingston, Philippe Goix.   

Abstract

BACKGROUND: Immunoassay (IA) technology has expanded the clinical utility of protein biomarkers, but demands for increased sensitivity, dynamic reporting ranges, and small sample volumes have limited the potential clinical usefulness of many biomarkers. We assessed the performance, including limits of detection (LODs) and the dynamic reporting range, of an IA-based technology, Erenna Immunoassay System, for a series of biomarkers, including cardiac troponin I (cTnI).
METHODS: Erenna IAs were used with 10 different and clinically important biomarkers to ascertain the LOD with various sample sizes (10 microL to 200 microL).
RESULTS: The Erenna Immunoassay System generated LODs of 10-100 pg/L using 100 microL of sample. For cTnI, the LOD was 0.2 ng/L and a 10% CV was seen between 0.78 and 1.6 ng/L.
CONCLUSIONS: The Erenna IA-based technology reproducibly measures protein biomarkers with detection limits of 10-100 pg/L, with a dynamic range of >4.5 logs in sample volumes of 50-150 microL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890441     DOI: 10.1373/clinchem.2007.091181

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  69 in total

1.  Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors.

Authors:  Keying Guo; Shofarul Wustoni; Anil Koklu; Escarlet Díaz-Galicia; Maximilian Moser; Adel Hama; Ahmed A Alqahtani; Adeel Nazir Ahmad; Fatimah Saeed Alhamlan; Muhammad Shuaib; Arnab Pain; Iain McCulloch; Stefan T Arold; Raik Grünberg; Sahika Inal
Journal:  Nat Biomed Eng       Date:  2021-05-24       Impact factor: 25.671

2.  Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; Petr Jarolim; Eugene Braunwald
Journal:  Eur Heart J       Date:  2008-11-08       Impact factor: 29.983

Review 3.  Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.

Authors:  Sherri Dudal; Daniel Baltrukonis; Rebecca Crisino; M Jaya Goyal; Alison Joyce; Karolina Osterlund; John Smeraglia; Yoshitaka Taniguchi; Jihong Yang
Journal:  AAPS J       Date:  2013-12-17       Impact factor: 4.009

Review 4.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

Review 5.  High-sensitivity cardiac troponins in everyday clinical practice.

Authors:  Johannes Mair
Journal:  World J Cardiol       Date:  2014-04-26

Review 6.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Authors:  J Gustav Smith; Robert E Gerszten
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

7.  Obstructive sleep apnea: no independent association to troponins.

Authors:  Trygve Sørdahl Hall; Tobias Herrscher; Petr Jarolim; Morten W Fagerland; Torstein Jensen; Jonas Hallén; Stefan Agewall; Dan Atar
Journal:  Sleep Breath       Date:  2013-09-17       Impact factor: 2.816

8.  Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.

Authors:  Thomas J Esparza; Hanzhi Zhao; John R Cirrito; Nigel J Cairns; Randall J Bateman; David M Holtzman; David L Brody
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

9.  Direct kinetic fingerprinting and digital counting of single protein molecules.

Authors:  Tanmay Chatterjee; Achim Knappik; Erin Sandford; Muneesh Tewari; Sung Won Choi; William B Strong; Evan P Thrush; Kenneth J Oh; Ning Liu; Nils G Walter; Alexander Johnson-Buck
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

10.  Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Authors:  Thomas J Wang; Kai C Wollert; Martin G Larson; Erin Coglianese; Elizabeth L McCabe; Susan Cheng; Jennifer E Ho; Michael G Fradley; Anahita Ghorbani; Vanessa Xanthakis; Tibor Kempf; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan; James L Januzzi
Journal:  Circulation       Date:  2012-08-20       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.